Sema4 Company
Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis™, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.
Investors
Founded Date:
2017-01-01
Technology:
Сancer Diagnostics
Funding Status:
IPO
Total Funding:
791000000.0
Employee Number:
501-1000
Headquarters:
Stamford, Connecticut, United States
Last Funding Date:
2022-01-18
Investors Number:
17.0
Last Funding Type:
Post-IPO Equity
Estimated Revenue:
$50M to $100M
Industry:
Data Processing